Reply to Xiaoshuai Gao, Guo Chen, and Xin Wei's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Pro- grammed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783-92

被引：0

|

作者：

Mori, Keiichiro ^{[1
,2
]}

Schmidinger, Manuela ^{[3
,4
]}

Egawa, Shin ^{[2
]}

Gust, Kilian M. ^{[1
]}

Shariat, Shahrokh F. ^{[1
]}

机构：

[1] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

[2] Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan

[3] Med Univ Vienna, Clin Div Oncol, Dept Med 1, Vienna, Austria

[4] Med Univ Vienna, Comprehens Canc Ctr, Vienna, Austria

来源：

EUROPEAN UROLOGY | 2021年 / 80卷 / 06期

关键词：

D O I：

10.1016/j.eururo.2021.09.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：E145 / E146

页数：2

相关论文

共 3 条

[1] Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Gao, Xiaoshuai
Chen, Guo
Wei, Xin
[J]. EUROPEAN UROLOGY, 2021, 80 (06) : E143 - E144
[2] Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006 Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
Noel, Johanna
Huillard, Olivier
Goldwasser, Francois
[J]. EUROPEAN UROLOGY, 2021, 79 (04) : E112 - E112
[3] Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
Mori, Keiichiro
Schmidinger, Manuela
Egawa, Shin
Gust, Kilian M.
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY, 2021, 79 (04) : E113 - E114